Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)
about
Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)
description
clinical trial
@en
klinisch onderzoek
@nl
name
Combination of Osimertinib and ...... mall Cell Lung Cancer ( NSCLC)
@en
type
label
Combination of Osimertinib and ...... mall Cell Lung Cancer ( NSCLC)
@en
prefLabel
Combination of Osimertinib and ...... mall Cell Lung Cancer ( NSCLC)
@en
P1476
A PHASE II,Single-arm Study to ...... nhibitor（EGFR-TKI） Osimertinib
@en
P3098
NCT03532698
P4844
P580
2018-07-01T00:00:00Z
P582
2019-06-30T00:00:00Z